Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Yu Mei Hsueh; Ying Chin Lin; Wei Jen Chen; Chao Yuan Huang; Horng Sheng Shiue; Yeong Shiau Pu; Chi Hung Chen; Chien Tien Su

doi:10.1016/j.taap.2018.07.022

Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Yu Mei Hsueh, Ying Chin Lin, Wei Jen Chen, Chao Yuan Huang, Horng Sheng Shiue, Yeong Shiau Pu, Chi Hung Chen, Chien Tien Su

Research output: Contribution to journal › Erratum › peer-review

Abstract

Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “^e” of Dr. Ying-Chin Lin, which was incorrectly given as. “^e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “^e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

Original language	English
Pages (from-to)	139
Number of pages	1
Journal	Toxicology and Applied Pharmacology
Volume	356
DOIs	https://doi.org/10.1016/j.taap.2018.07.022
Publication status	Published - Oct 1 2018

ASJC Scopus subject areas

Toxicology
Pharmacology

Access to Document

10.1016/j.taap.2018.07.022

Fingerprint

Dive into the research topics of 'Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))'. Together they form a unique fingerprint.

Cite this

Hsueh, Y. M., Lin, Y. C., Chen, W. J., Huang, C. Y., Shiue, H. S., Pu, Y. S., Chen, C. H., & Su, C. T. (2018). Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012)). Toxicology and Applied Pharmacology, 356, 139. https://doi.org/10.1016/j.taap.2018.07.022

Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012)). / Hsueh, Yu Mei; Lin, Ying Chin; Chen, Wei Jen et al.
In: Toxicology and Applied Pharmacology, Vol. 356, 01.10.2018, p. 139.

Research output: Contribution to journal › Erratum › peer-review

Hsueh, YM, Lin, YC, Chen, WJ, Huang, CY, Shiue, HS, Pu, YS, Chen, CH & Su, CT 2018, 'Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))', Toxicology and Applied Pharmacology, vol. 356, pp. 139. https://doi.org/10.1016/j.taap.2018.07.022

Hsueh YM, Lin YC, Chen WJ, Huang CY, Shiue HS, Pu YS et al. Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012)). Toxicology and Applied Pharmacology. 2018 Oct 1;356:139. doi: 10.1016/j.taap.2018.07.022

@article{c0b78cb91fef4628b36ae2a0c6b5d783,

title = "Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))",

abstract = "Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “e” of Dr. Ying-Chin Lin, which was incorrectly given as. “e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”",

author = "Hsueh, {Yu Mei} and Lin, {Ying Chin} and Chen, {Wei Jen} and Huang, {Chao Yuan} and Shiue, {Horng Sheng} and Pu, {Yeong Shiau} and Chen, {Chi Hung} and Su, {Chien Tien}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = oct,

day = "1",

doi = "10.1016/j.taap.2018.07.022",

language = "English",

volume = "356",

pages = "139",

journal = "Toxicology and Applied Pharmacology",

issn = "0041-008X",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

AU - Hsueh, Yu Mei

AU - Lin, Ying Chin

AU - Chen, Wei Jen

AU - Huang, Chao Yuan

AU - Shiue, Horng Sheng

AU - Pu, Yeong Shiau

AU - Chen, Chi Hung

AU - Su, Chien Tien

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “e” of Dr. Ying-Chin Lin, which was incorrectly given as. “e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

AB - Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “e” of Dr. Ying-Chin Lin, which was incorrectly given as. “e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

UR - http://www.scopus.com/inward/record.url?scp=85051638573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051638573&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2018.07.022

DO - 10.1016/j.taap.2018.07.022

M3 - Erratum

AN - SCOPUS:85051638573

SN - 0041-008X

VL - 356

SP - 139

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

ER -

Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this